Literature DB >> 8255079

Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.

S Nagai1, M Yamauchi, T Satta, Y Kodera, K Kondou, S Akiyaya, K Ito, H Takagi.   

Abstract

A water-soluble and stable camptothecin derivative, CPT-11, was found to possess a strong antitumor activity against various murine tumors. In the present study, CPT-11 was tested against ten human gastrointestinal cancer xenograft lines carried by nude mice. CPT-11 was very effective against nine xenograft lines, with the exception of one xenograft. On the other hand, VP-16 was ineffective against all these xenograft lines. Therefore, CPT-11 is expected to be clinically more effective against gastrointestinal cancer than the topo II targeting agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255079     DOI: 10.1002/jso.2930540404

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Targeting molecular pathways with camptothecin as novel therapy for gastric cancer.

Authors:  D A Litvak; H T Papaconstantinou; B M Evers; C M Townsend
Journal:  J Gastrointest Surg       Date:  1999 Nov-Dec       Impact factor: 3.452

2.  A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.

Authors:  Yuangang Zu; Dan Wang; Xiuhua Zhao; Ru Jiang; Qi Zhang; Dongmei Zhao; Yong Li; Baishi Zu; Zhiqiang Sun
Journal:  Int J Mol Sci       Date:  2011-06-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.